BRASPEN Journal
https://braspenjournal.org/article/doi/10.37111/braspenj.2017.32.2.11
BRASPEN Journal
Artigo Original

Oxidative stress and inflammatory parameters inpatients presenting celiac disease

Estresse oxidativo e parâmetros inflamatórios em pacientes com doença celíaca

Eliel Rovaris, Alexandre Faraco, Priscila Waleska Simões, Kristian Madeira, Samira Dal-Toé de Prá, Monique Michels, Andriele Vieira, Henrique Burger, Beatriz Sonai, Emilio Streck, Felipe Dal-Pizzol

Downloads: 0
Views: 163

Abstract

Objectives: Determine the presence of oxidative stress and inflammation in the gut of patients with celiac disease. Methods: Transversal study that included patients undergoing upper gastrointestinal endoscopy was performed. The study population consisted 24 cases and 26 controls. The duodenal levels of protein carbonyls, thiobarbituric acid reactive species, as well as catalase, superoxide dismutase (SOD) activities were measured. Gut levels of interleukin (IL) 6, 10 and 8 were also determined.The Marsh classification was recorded and used as a parameter of disease severity. Results: Both IL-6 and IL-10, but not IL8, were increased in celiac disease patients when compared to healthy individuals. Oxidative damage parameters were increased while antioxidant defenses were decreased in our sample. Both IL6 levels and SOD activity were related to Marsh score. Conclusions: Different markers of inflammation and oxidative stress are altered in the gut of celiac disease patients, and some of them are related to disease severity

Keywords

Celiac Disease. Gastroenterology. Oxidative Stress. Inflammatory Bowel Diseases

Resumo

Objetivos: Determinar a presença de estresse oxidativo e inflamação no intestino de pacientes com doença celíaca. Método: Foi realizado estudo transversal que incluiu pacientes submetidos à endoscopia gastrointestinal. A população do estudo consistiu em 24 casos e 26 controles. Foram medidos os níveis duodenais de proteínas carboniladas, espécies reativas ao ácido tiobarbitúrico, bem como catalase (CAT), superóxido dismutase (SOD). Também foram determinados os níveis intestinais de interleucina (IL) 6, 10 e 8. A classificação de Marsh foi registrada e utilizada como parâmetro de gravidade da doença. Resultados: Tanto a IL-6 como a IL-10, mas não a IL8, aumentaram nos pacientes com doença celíaca quando comparados com indivíduos saudáveis. Os parâmetros de dano oxidativo foram aumentados,enquanto que as defesas antioxidantes foram reduzidas em nossa amostra. Os níveis de IL6 ea atividade do SOD foram relacionados com a pontuação de Marsh. Conclusões: Diferentes marcadores de inflamação e estresse oxidativo estão alterados no intestino de pacientes com doença celíaca, e alguns deles estão relacionados à gravidade da doença.

Palavras-chave

Doença Celíaca. Gastroenterologia. Estresse Oxidativo. Doenças Inflamatórias Intestinais

Referências

1. Gama e Silva TS, Furlanetto TW. Diagnóstico de doença celíaca em adultos. Rev Assoc Med Bras. 2010;56(1):122-6.

2. Beitnes AR, Ráki M, Brottveit M, Lundin KE, Jahnsen FL, Sollid LM. Rapid accumulation of CD14+CD11c+ dendritic cells in gut mucosa of celiac disease after in vivo gluten challenge. PLoS One. 2012;7(3):e33556.

3. Eiró N, González-Reyes S, González L, González LO, Altadill A, Andicoechea A, et al.Duodenal expression of Toll-like receptors and interleukins are increased in both children and adult celiac patients. Dig Dis Sci. 2012;57(9):2278-85.

4. Kalliomäki M, Satokari R, Lähteenoja H, Vähämiko S, Grönlund J, RoutiT, et al.Expression of microbiota, Toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease. J Pediatr Gastroenterol Nutr. 2012;54(6):727-32.

5. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA; American College of Gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656-76.

6. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al.Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464-78.

7. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186:421-31.

8. Bannister JV, Calabrese L. Assays for superoxide dismutase. Methods Biochem Anal. 1987;32:279-312.

9. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-6.

10. Benjamin D, Knoblock TJ, Dayton MA. Human B cell interleukin- 10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt’s lymphoma constitutively secrete large quantities of interleukine-10. Blood. 1992;80(5):1289-98.

11. Frisullo G, Nociti V, Iorio R, Patanella AK, Marti A, Assunta B, et al. Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. Hum Immunol. 2009;70(6):430-5.

12. McSorley HJ, Gaze S, Daveson J, Jones D, Anderson RP, Clouston A, et al.Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection.PLoS One. 2011;6(9):e24092.

13. Borrelli M, Salvati VM, Maglio M, Zanzi D, Ferrara K, Santagata S, et al. Immunoregulatory pathways are active in the small intestinal mucosa of patients with potential celiac disease. Am J Gastroenterol. 2013;108(11):1775-84.

14. Kontakou M, Przemioslo RT, Sturgess RP, Limb GA, Ellis HJ, Day P, et al. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge.Gut. 1995;37(1):52-7.

15. Planell N, Lozano JJ, Mora-Buch R, Masamunt MC, Jimeno M, Ordás I, et al.Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations.Gut. 2013;62(7):967-76.

16. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, et al. Association between innate response to gliadin and activation of pathogenic T cells in celiac disease. Lancet. 2003;362(9377):30-7.

17. Luciani A, Villella VR, Vasaturo A, Giardino I, Pettoello-Mantovani M, Guido S, et al.Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress and tissue transglutaminasemediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa. Gut. 2010;59(3):311-9.

18. Lavö B, Knutson L, Lööf L, HällgrenR. Gliadin challengeinduced jejunal prostaglandin E2 secretion in celiac disease. Gastroenterology. 1990;99(3):703-9.

19. Stojiljković V, TodorovićA, Pejić S, Kasapović J, Saicić ZS, Radlović N, et al.Antioxidant status and lipid peroxidation in small intestinal mucosa of children with celiac disease. ClinBiochem. 2009;42(13-14):1431-7.

20. Calder PC, Albers R, Antoine JM, Blum S, Bourdet-Sicard R, Ferns GA, et al.Inflammatory disease processes and interactions with nutrition.Br J Nutr. 2009;101(Suppl 1):S1-45.


Submetido em:
19/08/2016

Aceito em:
31/10/2016

65564ec1a9539539e30c0db1 braspen Articles
Links & Downloads

BRASPEN Journal

Share this page
Page Sections